Atossa Therapeutics Selects PSI as Contract Research Organization for Pivotal Dose-Ranging Study of (Z)-Endoxifen in Metastatic Breast Cancer
New EASL Guidelines Aim to Improve Diagnostic Accuracy and Outcomes for AIH Patients